Skip to main content

Advertisement

SpringerLink
Log in

The Diagnosis of Posttransplantation Diabetes Mellitus: Meeting the Challenges

  • Other Forms of Diabetes (R Bonadonna, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Posttransplantation diabetes mellitus (PTDM) is a major complication after renal transplantation due to its negative impact on patient and graft survival, and affects up to 40 % of renal transplant recipients. The generation of evidence regarding its optimal treatment is now progressing with some emphasis on early postoperative insulin treatment that targets β-cell failure. This therapy seems to benefit renal transplant patients but contrasts with previous PTDM guidelines that were following treatment of type 2 diabetes mellitus (DM): oral antidiabetics first, insulin last. Similarly, in the current PTDM consensus recommendations, diagnostic procedures are in accordance with the American Diabetes Association (ADA) recommendations for diagnosis of DM. PTDM and type 2 DM, however, are distinct disease entities with different pathophysiological backgrounds. This review will discuss the significance of the standard diagnostic criteria for DM in patients after renal transplantation without prior DM. In particular, the role of glycated hemoglobin (HbA1c) and oral glucose tolerance testing (OGTT) will be reviewed. In addition, the potential role of other glycated proteins and continuous glucose monitoring will be covered, although these parameters are not yet part of the consensus recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Chapman JR. What are the key challenges we face in kidney transplantation today? Transplant Res. 2013;2 Suppl 1:S1.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Starzl TE. Postoperative care and surgical complications. In: Experience in renal transplantation, Chapter 12, p 117. Philadelphia: Saunders; 1964.

  3. Sharif A, Baboolal K. Complications associated with new-onset diabetes after kidney transplantation. Nat Rev Nephrol. 2012;8(1):34–42. A useful review of the available evidence about complications caused by development of PTDM.

    Article  CAS  Google Scholar 

  4. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation. 2003;75(10 Suppl):SS3–24.

    PubMed  Google Scholar 

  5. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant. 2005;19(3):291–8.

    Article  PubMed  Google Scholar 

  6. Sharif A, Hecking M, De Vries AP, Porrini E, Hornum M, Rasoul-Rockenschaub S, Berlakovich G, Krebs M, Kautzky-Willer A, Schernthaner G, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am J Transplant. 2014;14(9):1992–2000. This report summarizes the current consensus recommendations for the management of PTDM and future directions for research.

  7. Zelle DM, Corpeleijn E, Deinum J, Stolk RP, Gans RO, Navis G, Bakker SJ. Pancreatic beta-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care. 2013;36(7):1926–32.

  8. Hecking M, Kainz A, Werzowa J, Haidinger M, Doller D, Tura A, Karaboyas A, Horl WH, Wolzt M, Sharif A, et al. Glucose metabolism after renal transplantation. Diabetes Care. 2013;36(9):2763–71.

  9. Fang J, Huang C, Chuang C, Chu S. Diabetes mellitus after renal transplantation. Transplant Proc. 1998;30(7):3027–8.

    Article  CAS  PubMed  Google Scholar 

  10. US Renal Data System, Annual Report 2011. http://www.usrds.org/2011/view/v2_07.asp. Accessed 23 June 2014.

  11. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62–9.

    Google Scholar 

  12. Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, et al. Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care. 2007;30(3):609–15.

    Article  PubMed  Google Scholar 

  13. Valderhaug TG, Hjelmesaeth J, Hartmann A, Roislien J, Bergrem HA, Leivestad T, et al. The association of early post-transplant glucose levels with long-term mortality. Diabetologia. 2011;54(6):1341–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Hecking M, Haidinger M, Doller D, Werzowa J, Tura A, Zhang J, et al. Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol. 2012;23(4):739–49.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, et al. Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol. 2009;4(4):853–9. An important study highlighting the excessive rates of hyperglycemia after kidney transplantation.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001;59(2):732–7.

    Article  CAS  PubMed  Google Scholar 

  17. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006. http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/. Accessed 23 June 2014.

  18. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–9.

    Article  CAS  PubMed  Google Scholar 

  19. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19(9):708–23.

    Article  CAS  PubMed  Google Scholar 

  20. Sharif A, Moore RH, Baboolal K. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon. Transplantation. 2006;82(12):1667–72.

    Article  PubMed  Google Scholar 

  21. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: collaborative analysis of Diagnostic Criteria in Europe. Diabetologia. 1999, 42(6):647–654.

  22. Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation. 2009;88(3):429–34.

    Article  PubMed  Google Scholar 

  23. Mak RH. Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial. 2000;13(1):4–8.

    Article  CAS  PubMed  Google Scholar 

  24. Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, et al. Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol. 2010;5(4):616–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. American Diabetes A. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37 Suppl 1:S14–80.

    Article  Google Scholar 

  26. Shah A, Kendall G, Demme RA, Taylor J, Bozorgzadeh A, Orloff M, et al. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation. 2005;80(6):775–81. An interesting study showing that home-glucometer monitoring may be the best means for the detection of PTDM.

    Article  PubMed  Google Scholar 

  27. Mollar-Puchades MA, Malek-Marin T, Merino-Torres JF, Ramos-Escorihuela D, Sanchez-Plumed J, Pinon-Selles F. Diabetes mellitus after kidney transplantation: role of the impaired fasting glucose in the outcome of kidney transplantation. J Endocrinol Investig. 2009;32(3):263–6.

    Article  CAS  Google Scholar 

  28. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.

    Article  CAS  PubMed  Google Scholar 

  29. Healy GN, Dunstan DW, Shaw JE, Zimmet PZ, Owen N. Beneficial associations of physical activity with 2-h but not fasting blood glucose in Australian adults: the AusDiab study. Diabetes Care. 2006;29(12):2598–604.

    Article  CAS  PubMed  Google Scholar 

  30. Sharif A, Moore R, Baboolal K. Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia. Transplantation. 2008;85(3):353–8.

    Article  PubMed  Google Scholar 

  31. Werzowa J, Hecking M, Haidinger M, Lechner F, Doller D, Pacini G, et al. Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial. Transplantation. 2013;95(3):456–62.

    Article  CAS  PubMed  Google Scholar 

  32. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem. 1998;35(Pt 1):62–7.

    Article  PubMed  Google Scholar 

  33. International Expert C. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–34.

    Article  Google Scholar 

  34. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J Clin Invest. 1976;57(6):1652–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Davenport A, Jones S, Goel S, Astley JP, Feest TG. Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage renal failure. Kidney Int. 1996;50(4):1344–51.

    Article  CAS  PubMed  Google Scholar 

  36. De Marchi S, Cecchin E, Basile A, Donadon W, Lippi U, Quaia P, et al. More on the increase of hemoglobin A1 in chronic renal failure: the role of acidosis. Nephron. 1983;35(1):49–53.

    Article  PubMed  Google Scholar 

  37. Chudnovsky Y, Khavari PA, Adams AE. Melanoma genetics and the development of rational therapeutics. J Clin Invest. 2005;115(4):813–24.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126–8.

    Article  CAS  PubMed  Google Scholar 

  39. Shah N, Al-Khoury S, Afzali B, Covic A, Roche A, Marsh J, et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation. 2006;81(8):1112–8.

    Article  PubMed  Google Scholar 

  40. Hoban R, Gielda B, Temkit M, Saha C, Book BK, Baker E, et al. Utility of HbA1c in the detection of subclinical post renal transplant diabetes. Transplantation. 2006;81(3):379–83.

    Article  CAS  PubMed  Google Scholar 

  41. Shabir S, Jham S, Harper L, Ball S, Borrows R, Sharif A. Validity of glycated haemoglobin to diagnose new onset diabetes after transplantation. Transpl Int. 2013;26(3):315–21.

  42. Yates CJ, Fourlanos S, Colman PG, Cohney SJ. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. Transplantation. 2013;96(8):726–31.

    Article  CAS  PubMed  Google Scholar 

  43. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28(5):1231–9.

    Article  PubMed  Google Scholar 

  44. Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2012;1:CD008101.

    PubMed  Google Scholar 

  45. Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11 Suppl 1:S55–67.

    CAS  PubMed  Google Scholar 

  46. Thomas A, Heinemann L. Prediction of the risk to develop diabetes-related late complications by means of the glucose pentagon model: analysis of data from the juvenile diabetes research foundation continuous glucose monitoring study. J Diabetes Sci Technol. 2012;6(3):572–80.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Chantrel F, Sissoko H, Kepenekian L, Smagala A, Meyer L, Imhoff O, Serb L, Fleury D, Dorey F, Krummel T, et al. Influence of dialysis on the glucose profile in patients with diabetes: usefulness of continuous glucose monitoring. Horm Metab Res Hormon- und Stoffwechselforschung Horm Metab. 2014;46(11):810–3.

  48. Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013;36(7):1877–83.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  49. Werzowa J, Pacini G, Brath H, Säemann M, Tura A. Glycemic variability and glucose control in post-transplant diabetes mellitus after renal transplantation. In: EASD annual conference, poster session: 114;poster:1272; Vienna; 2014.

  50. Yates CJ, Fourlanos S, Colman PG, Cohney SJ. Divided dosing reduces prednisolone-induced hyperglycaemia and glycaemic variability: a randomized trial after kidney transplantation. Nephrol Dial Transplant. 2013;29(3):698–705.

  51. Pasti K, Szabo AJ, Prokai A, Meszaros K, Peko N, Solyom R, et al. Continuous glucose monitoring system (CGMS) in kidney-transplanted children. Pediatr Transplant. 2013;17(5):454–60.

    Article  CAS  PubMed  Google Scholar 

  52. Rodriguez LM, Knight RJ, Heptulla RA. Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation. Diabetes Technol Ther. 2010;12(5):347–51.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Wojtusciszyn A, Mourad G, Bringer J, Renard E. Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure. Diabetes Metab. 2013;39(5):404–10.

    Article  CAS  PubMed  Google Scholar 

  54. Choudhary A, Giardina P, Antal Z, Vogiatzi M. Unreliable oral glucose tolerance test and haemoglobin A1C in beta thalassaemia major—a case for continuous glucose monitoring? Br J Haematol. 2013;162(1):132–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Klonoff DC. Serum fructosamine as a screening test for type 2 diabetes. Diabetes Technol Ther. 2000;2(4):537–9.

    Article  CAS  PubMed  Google Scholar 

  56. Baker JR, O’Connor JP, Metcalf PA, Lawson MR, Johnson RN. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J (Clin Res Ed). 1983;287(6396):863–7.

    Article  CAS  Google Scholar 

  57. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta Int J Clin Chem. 1983;127(1):87–95.

    Article  CAS  Google Scholar 

  58. Lindsey CC, Carter AW, Mangum S, Greene D, Richardson A, Brown SJ, et al. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care. Diabetes Technol Ther. 2004;6(3):370–7.

    Article  PubMed  Google Scholar 

  59. Morgan L, Marenah CB, Jeffcoate WJ, Morgan AG. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure. Diabet Med. 1996;13(6):514–9.

    Article  CAS  PubMed  Google Scholar 

  60. Morgan LJ, Marenah CB, Morgan AG, Burden RP, John WG. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure. Nephrol Dial Transplant. 1990;5(10):868–73.

    Article  CAS  PubMed  Google Scholar 

  61. Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton). 2011;17(2):182–8.

    Article  Google Scholar 

  62. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18(3):896–903.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

A. Tura reports grants from the Clinical Division of Nephrology & Dialysis (CDND), Internal Medicine III, Medical University of Vienna.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

J. Werzowa, M. Hecking, M. Haidinger, D. Döller, A. Sharif, A. Tura, and M. D. Säemann declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Internal Medicine III, Section of Nephrology and Dialysis, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria

    J. Werzowa, M. Hecking, M. Haidinger, D. Döller & M. D. Säemann

  2. Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK

    A. Sharif

  3. Metabolic Unit, Institute of Biomedical Engineering, National Research Council, Padova, Italy

    A. Tura

Authors
  1. J. Werzowa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Hecking
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Haidinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Döller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Sharif
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Tura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. D. Säemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Werzowa.

Additional information

This article is part of the Topical Collection on Other Forms of Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Werzowa, J., Hecking, M., Haidinger, M. et al. The Diagnosis of Posttransplantation Diabetes Mellitus: Meeting the Challenges. Curr Diab Rep 15, 27 (2015). https://doi.org/10.1007/s11892-015-0601-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-015-0601-x

Keywords

Search

Navigation